National guidelines for diagnosis and treatment of malignant lymphoma 2022 in China (English version)

National Health Commission of the People’s Republic of China

2022, 34(5): 425-446. doi: 10.21147/j.issn.1000-9604.2022.05.01

Comments on National guidelines for diagnosis and treatment of thyroid cancer 2022 in China (English version)

Hao Wang, Jian Wang, Xiang Wang, Yiming Zhu, Yuqing Sun, Xin Zhang, Xiaorong Hou, Kun Zheng, Shaoyan Liu, Yansong Lin

2022, 34(5): 447-450. doi: 10.21147/j.issn.1000-9604.2022.05.02

Comments on National guidelines for diagnosis and treatment of breast cancer 2022 in China (English version)

Xinguang Wang, Zhaoqing Fan

2022, 34(5): 451-452. doi: 10.21147/j.issn.1000-9604.2022.05.03

Comments on National guidelines for diagnosis and treatment of gastric cancer 2022 in China (English version)

Jiahui Chen, Zhaode Bu, Jiafu Ji

2022, 34(5): 453-455. doi: 10.21147/j.issn.1000-9604.2022.05.04

Comments on National guidelines for diagnosis and treatment of prostate cancer 2022 in China (English version)

Yong Yang

2022, 34(5): 456-457. doi: 10.21147/j.issn.1000-9604.2022.05.05

Comments on National guidelines for diagnosis and treatment of cervical cancer 2022 in China (English version)

Naiyi Zhang, Yunong Gao

2022, 34(5): 458-459. doi: 10.21147/j.issn.1000-9604.2022.05.06

Myeloid checkpoints for cancer immunotherapy

Yixin Qian, Ting Yang, Huan Liang, Mi Deng

2022, 34(5): 460-482. doi: 10.21147/j.issn.1000-9604.2022.05.07

Colorectal cancer burden, trends and risk factors in China: A review and comparison with the United States

Qianru Li, Hongliang Wu, Maomao Cao, He Li, Siyi He, Fan Yang, Xinxin Yan, Shaoli Zhang, Yi Teng, Changfa Xia, Ji Peng, Wanqing Chen

2022, 34(5): 483-495. doi: 10.21147/j.issn.1000-9604.2022.05.08

Evaluation of triage strategies for high-risk human papillomavirus-positive women in cervical cancer screening: A multicenter randomized controlled trial in different resource settings in China

Le Dang, Linghua Kong, Yuqian Zhao, Yi Dai, Li Ma, Lihui Wei, Shulan Zhang, Jihong Liu, Mingrong Xi, Long Chen, Xianzhi Duan, Qing Xiao, Guzhalinuer Abulizi, Guonan Zhang, Ying Hong, Qi Zhou, Xing Xie, Li Li, Mayinuer Niyazi, Zhifen Zhang, Jiyu Tuo, Yiling Ding, Youlin Qiao, Jinghe Lang

2022, 34(5): 496-509. doi: 10.21147/j.issn.1000-9604.2022.05.09

Correlation between imaging features on computed tomography and combined positive score of PD-L1 expression in patients with gastric cancer

Zhilong Wang, Yinkui Wang, Xiaoting Li, Yanling Li, Zhaode Bu, Zhongwu Li, Yingshi Sun, Jiafu Ji

2022, 34(5): 510-518. doi: 10.21147/j.issn.1000-9604.2022.05.10

Characteristics of lymph node stations/basins metastasis and construction and validation of a preoperative combination prediction model that accurately excludes lymph node metastasis in early gastric cancer

Mengyu Feng, Jingtao Wei, Ke Ji, Yinan Zhang, Heli Yang, Xiaojiang Wu, Ji Zhang, Zhaode Bu, Jiafu Ji

2022, 34(5): 519-532. doi: 10.21147/j.issn.1000-9604.2022.05.11

Perspectives of laparoscopic surgery for gastric cancer

Jeong Ho Song, Sang-Uk Han

2022, 34(5): 533-538. doi: 10.21147/j.issn.1000-9604.2022.05.12

Beyond images: Emerging role of Raman spectroscopy-based artificial intelligence in diagnosis of gastric neoplasia

Khek Yu Ho

2022, 34(5): 539-542. doi: 10.21147/j.issn.1000-9604.2022.05.13